<DOC>
	<DOCNO>NCT02259257</DOCNO>
	<brief_summary>Contrast enhance 3D/4D ( 3 dimension/4 dimension ) ultrasound ( CEUS ) provide visualization dynamic vascular feature plaque , unique spatial format use three orthogonal plane angiogram-like image . Therefore , observer utilize entire vascular system volumetric manner ( 3D ) . The rotation intra-plaque neovasculature view various angle provide realistic representation easily appreciate . Inter-observer variability individual plaque assess inter-observer variability inter-scan variability ( analysis multiple image single patient longitudinal study ) dependent plaque size , large plaque show low variability . Therefore , propose 3D/4D vs. 2D CEUS image carotid plaque provide add value depiction quantification intra-plaque blood vessel density provide true volumetric view area . This data correlate subsequent surgical specimen . The goal protocol investigate correlation intra-plaque blood vessel density hemorrhage 3D/4D CEUS vas vasorum use quantitative software analysis . The histology method use quantification hemorrhage vessel density analysis .</brief_summary>
	<brief_title>3D/4D Ultrasound Contrast Enhanced Imaging ( CEUS ) Carotid Plaque Vulnerability</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Adult subject know carotid artery disease include . Subject must able willing comply study procedure provide sign date informed consent include consent 3 year annual follow . Subjects screen ask study subject know suspected hypersensitivity component Optison , blood , blood product albumin . In addition , study subject ask right leave bidirectional transient right leave cardiac shunt . If question answer positive , patient eligible inclusion study . Female subject child bear potential exclude . The subject present clinically active , serious , lifethreatening disease , life expectancy le 1 month study participation may compromise management subject reason judgment investigator make subject unsuitable participation study . History acute occlusion require medical intervention artery ( include aorta ) within 6 month consent . Has know suspect hypersensitivity component Optison , blood , blood product , albumin . Has know right left , bidirectional transient right leave cardiac shunt . Any known contraindication list current Optison package insert .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>carotid arteriosclerosis</keyword>
	<keyword>contrast-enhanced ultrasound</keyword>
	<keyword>neovascularization</keyword>
	<keyword>quantitative analysis</keyword>
	<keyword>3D/4D imaging</keyword>
	<keyword>CEUS</keyword>
	<keyword>Vasa vasorum</keyword>
</DOC>